Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship

Background The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and joint surgery. American volume 2015-08, Vol.97 (15), p.1220-1232
Hauptverfasser: Siqueira, Marcelo B.P., MD, Saleh, Anas, MD, Klika, Alison K., MS, Higuera, Carlos A., MD, Barsoum, Wael K., MD, O’Rourke, Colin, MS, Schmitt, Steven, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1232
container_issue 15
container_start_page 1220
container_title Journal of bone and joint surgery. American volume
container_volume 97
creator Siqueira, Marcelo B.P., MD
Saleh, Anas, MD
Klika, Alison K., MS
Higuera, Carlos A., MD
Barsoum, Wael K., MD
O’Rourke, Colin, MS
Schmitt, Steven, MD
description Background The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who did not following irrigation and debridement with polyethylene exchange or two-stage revision for periprosthetic joint infection. Methods We reviewed the records on all irrigation and debridement procedures with polyethylene exchange and two-stage revisions performed at our institution from 1996 to 2010 for hip or knee periprosthetic joint infection. Of 625 patients treated with a total of 655 eligible revisions, ninety-two received chronic oral antibiotics for a minimum of six months and were eligible for inclusion in our study. These patients were compared with a matched cohort (ratio of 1:3) who did not receive chronic oral antibiotics. Results The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p < 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047). Conclusions Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit. Level of Evidence Therapeutic Level III . See the Instructions for Authors for a complete description of levels of evidence.
doi_str_mv 10.2106/JBJS.N.00999
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811909819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0021935515302125</els_id><sourcerecordid>1811909819</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4672-be675e1b19c20a6d5f0b82794e6784b2419f631bbbaae8871cb2cddeb3f21ef73</originalsourceid><addsrcrecordid>eNqFkkFv1DAQhS0EokvhxhnlyIEsYyd24gtSu6LQVdUiLZwtOztR3GbjxU521X_PhC1w5GRr_M2T_N5j7C2HpeCgPq4v15vl7RJAa_2MLbgsZM6LWj1nCwDBc11IecZepXQPAGUJ1Ut2JpQolZBqweKqi2HwTbaZ9vuIKfkwZKHNvmH0-xjS2OFIr-vghzG7HlpsRiJSdvRjl91F22cXw-idD0QlApqINmH6h-ZXEZHU48EfQkyd379mL1rbJ3zzdJ6zH1efv6--5jd3X65XFzd5U6pK5A5VJZE7rhsBVm1lC64WlS5pXpdOlFy3quDOOWuxriveONFst-iKVnBsq-KcvT_p0j9-TphGs_Opwb63A4YpGV5zrkHXXP8frUAoqaqyIPTDCW3InRSxNfvodzY-Gg5mDsTMgZhb8zsQwt89KU9uh9u_8J8ECChPwDH0I8b00E9HjKZD248diVBmShS5AC6hBgn5PBK09um0huTgwdNG03vK0fYP-IjpPkxxIHMNN0kYMJu5CnMTqB50E7L4BXwkrGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1702656743</pqid></control><display><type>article</type><title>Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Siqueira, Marcelo B.P., MD ; Saleh, Anas, MD ; Klika, Alison K., MS ; Higuera, Carlos A., MD ; Barsoum, Wael K., MD ; O’Rourke, Colin, MS ; Schmitt, Steven, MD</creator><creatorcontrib>Siqueira, Marcelo B.P., MD ; Saleh, Anas, MD ; Klika, Alison K., MS ; Higuera, Carlos A., MD ; Barsoum, Wael K., MD ; O’Rourke, Colin, MS ; Schmitt, Steven, MD</creatorcontrib><description>Background The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who did not following irrigation and debridement with polyethylene exchange or two-stage revision for periprosthetic joint infection. Methods We reviewed the records on all irrigation and debridement procedures with polyethylene exchange and two-stage revisions performed at our institution from 1996 to 2010 for hip or knee periprosthetic joint infection. Of 625 patients treated with a total of 655 eligible revisions, ninety-two received chronic oral antibiotics for a minimum of six months and were eligible for inclusion in our study. These patients were compared with a matched cohort (ratio of 1:3) who did not receive chronic oral antibiotics. Results The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p &lt; 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047). Conclusions Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit. Level of Evidence Therapeutic Level III . See the Instructions for Authors for a complete description of levels of evidence.</description><identifier>ISSN: 0021-9355</identifier><identifier>EISSN: 1535-1386</identifier><identifier>DOI: 10.2106/JBJS.N.00999</identifier><identifier>PMID: 26246256</identifier><language>eng</language><publisher>United States: Copyright by The Journal of Bone and Joint Surgery, Incorporated</publisher><subject>Administration, Oral ; Aged ; Anti-Bacterial Agents - administration &amp; dosage ; Arthroplasty, Replacement, Hip - adverse effects ; Arthroplasty, Replacement, Hip - methods ; Arthroplasty, Replacement, Knee - adverse effects ; Arthroplasty, Replacement, Knee - methods ; Case-Control Studies ; Confidence Intervals ; Databases, Factual ; Debridement - methods ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Hip Prosthesis - adverse effects ; Humans ; Kaplan-Meier Estimate ; Knee Prosthesis - adverse effects ; Long-Term Care ; Male ; Middle Aged ; Multivariate Analysis ; Orthopedics ; Proportional Hazards Models ; Prosthesis Failure ; Prosthesis-Related Infections - drug therapy ; Prosthesis-Related Infections - epidemiology ; Prosthesis-Related Infections - microbiology ; Retrospective Studies ; Risk Assessment ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - etiology ; Staphylococcus aureus ; Treatment Outcome</subject><ispartof>Journal of bone and joint surgery. American volume, 2015-08, Vol.97 (15), p.1220-1232</ispartof><rights>The Journal of Bone and Joint Surgery, Inc.</rights><rights>Copyright 2015 by The Journal of Bone and Joint Surgery, Incorporated</rights><rights>Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4672-be675e1b19c20a6d5f0b82794e6784b2419f631bbbaae8871cb2cddeb3f21ef73</citedby><cites>FETCH-LOGICAL-c4672-be675e1b19c20a6d5f0b82794e6784b2419f631bbbaae8871cb2cddeb3f21ef73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26246256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siqueira, Marcelo B.P., MD</creatorcontrib><creatorcontrib>Saleh, Anas, MD</creatorcontrib><creatorcontrib>Klika, Alison K., MS</creatorcontrib><creatorcontrib>Higuera, Carlos A., MD</creatorcontrib><creatorcontrib>Barsoum, Wael K., MD</creatorcontrib><creatorcontrib>O’Rourke, Colin, MS</creatorcontrib><creatorcontrib>Schmitt, Steven, MD</creatorcontrib><title>Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship</title><title>Journal of bone and joint surgery. American volume</title><addtitle>J Bone Joint Surg Am</addtitle><description>Background The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who did not following irrigation and debridement with polyethylene exchange or two-stage revision for periprosthetic joint infection. Methods We reviewed the records on all irrigation and debridement procedures with polyethylene exchange and two-stage revisions performed at our institution from 1996 to 2010 for hip or knee periprosthetic joint infection. Of 625 patients treated with a total of 655 eligible revisions, ninety-two received chronic oral antibiotics for a minimum of six months and were eligible for inclusion in our study. These patients were compared with a matched cohort (ratio of 1:3) who did not receive chronic oral antibiotics. Results The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p &lt; 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047). Conclusions Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit. Level of Evidence Therapeutic Level III . See the Instructions for Authors for a complete description of levels of evidence.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Arthroplasty, Replacement, Hip - adverse effects</subject><subject>Arthroplasty, Replacement, Hip - methods</subject><subject>Arthroplasty, Replacement, Knee - adverse effects</subject><subject>Arthroplasty, Replacement, Knee - methods</subject><subject>Case-Control Studies</subject><subject>Confidence Intervals</subject><subject>Databases, Factual</subject><subject>Debridement - methods</subject><subject>Disease-Free Survival</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hip Prosthesis - adverse effects</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Knee Prosthesis - adverse effects</subject><subject>Long-Term Care</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Orthopedics</subject><subject>Proportional Hazards Models</subject><subject>Prosthesis Failure</subject><subject>Prosthesis-Related Infections - drug therapy</subject><subject>Prosthesis-Related Infections - epidemiology</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - etiology</subject><subject>Staphylococcus aureus</subject><subject>Treatment Outcome</subject><issn>0021-9355</issn><issn>1535-1386</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkFv1DAQhS0EokvhxhnlyIEsYyd24gtSu6LQVdUiLZwtOztR3GbjxU521X_PhC1w5GRr_M2T_N5j7C2HpeCgPq4v15vl7RJAa_2MLbgsZM6LWj1nCwDBc11IecZepXQPAGUJ1Ut2JpQolZBqweKqi2HwTbaZ9vuIKfkwZKHNvmH0-xjS2OFIr-vghzG7HlpsRiJSdvRjl91F22cXw-idD0QlApqINmH6h-ZXEZHU48EfQkyd379mL1rbJ3zzdJ6zH1efv6--5jd3X65XFzd5U6pK5A5VJZE7rhsBVm1lC64WlS5pXpdOlFy3quDOOWuxriveONFst-iKVnBsq-KcvT_p0j9-TphGs_Opwb63A4YpGV5zrkHXXP8frUAoqaqyIPTDCW3InRSxNfvodzY-Gg5mDsTMgZhb8zsQwt89KU9uh9u_8J8ECChPwDH0I8b00E9HjKZD248diVBmShS5AC6hBgn5PBK09um0huTgwdNG03vK0fYP-IjpPkxxIHMNN0kYMJu5CnMTqB50E7L4BXwkrGw</recordid><startdate>20150805</startdate><enddate>20150805</enddate><creator>Siqueira, Marcelo B.P., MD</creator><creator>Saleh, Anas, MD</creator><creator>Klika, Alison K., MS</creator><creator>Higuera, Carlos A., MD</creator><creator>Barsoum, Wael K., MD</creator><creator>O’Rourke, Colin, MS</creator><creator>Schmitt, Steven, MD</creator><general>Copyright by The Journal of Bone and Joint Surgery, Incorporated</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7TS</scope><scope>C1K</scope></search><sort><creationdate>20150805</creationdate><title>Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship</title><author>Siqueira, Marcelo B.P., MD ; Saleh, Anas, MD ; Klika, Alison K., MS ; Higuera, Carlos A., MD ; Barsoum, Wael K., MD ; O’Rourke, Colin, MS ; Schmitt, Steven, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4672-be675e1b19c20a6d5f0b82794e6784b2419f631bbbaae8871cb2cddeb3f21ef73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Arthroplasty, Replacement, Hip - adverse effects</topic><topic>Arthroplasty, Replacement, Hip - methods</topic><topic>Arthroplasty, Replacement, Knee - adverse effects</topic><topic>Arthroplasty, Replacement, Knee - methods</topic><topic>Case-Control Studies</topic><topic>Confidence Intervals</topic><topic>Databases, Factual</topic><topic>Debridement - methods</topic><topic>Disease-Free Survival</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hip Prosthesis - adverse effects</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Knee Prosthesis - adverse effects</topic><topic>Long-Term Care</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Orthopedics</topic><topic>Proportional Hazards Models</topic><topic>Prosthesis Failure</topic><topic>Prosthesis-Related Infections - drug therapy</topic><topic>Prosthesis-Related Infections - epidemiology</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - etiology</topic><topic>Staphylococcus aureus</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siqueira, Marcelo B.P., MD</creatorcontrib><creatorcontrib>Saleh, Anas, MD</creatorcontrib><creatorcontrib>Klika, Alison K., MS</creatorcontrib><creatorcontrib>Higuera, Carlos A., MD</creatorcontrib><creatorcontrib>Barsoum, Wael K., MD</creatorcontrib><creatorcontrib>O’Rourke, Colin, MS</creatorcontrib><creatorcontrib>Schmitt, Steven, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Physical Education Index</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of bone and joint surgery. American volume</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siqueira, Marcelo B.P., MD</au><au>Saleh, Anas, MD</au><au>Klika, Alison K., MS</au><au>Higuera, Carlos A., MD</au><au>Barsoum, Wael K., MD</au><au>O’Rourke, Colin, MS</au><au>Schmitt, Steven, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship</atitle><jtitle>Journal of bone and joint surgery. American volume</jtitle><addtitle>J Bone Joint Surg Am</addtitle><date>2015-08-05</date><risdate>2015</risdate><volume>97</volume><issue>15</issue><spage>1220</spage><epage>1232</epage><pages>1220-1232</pages><issn>0021-9355</issn><eissn>1535-1386</eissn><abstract>Background The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who did not following irrigation and debridement with polyethylene exchange or two-stage revision for periprosthetic joint infection. Methods We reviewed the records on all irrigation and debridement procedures with polyethylene exchange and two-stage revisions performed at our institution from 1996 to 2010 for hip or knee periprosthetic joint infection. Of 625 patients treated with a total of 655 eligible revisions, ninety-two received chronic oral antibiotics for a minimum of six months and were eligible for inclusion in our study. These patients were compared with a matched cohort (ratio of 1:3) who did not receive chronic oral antibiotics. Results The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p &lt; 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047). Conclusions Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit. Level of Evidence Therapeutic Level III . See the Instructions for Authors for a complete description of levels of evidence.</abstract><cop>United States</cop><pub>Copyright by The Journal of Bone and Joint Surgery, Incorporated</pub><pmid>26246256</pmid><doi>10.2106/JBJS.N.00999</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9355
ispartof Journal of bone and joint surgery. American volume, 2015-08, Vol.97 (15), p.1220-1232
issn 0021-9355
1535-1386
language eng
recordid cdi_proquest_miscellaneous_1811909819
source MEDLINE; Alma/SFX Local Collection
subjects Administration, Oral
Aged
Anti-Bacterial Agents - administration & dosage
Arthroplasty, Replacement, Hip - adverse effects
Arthroplasty, Replacement, Hip - methods
Arthroplasty, Replacement, Knee - adverse effects
Arthroplasty, Replacement, Knee - methods
Case-Control Studies
Confidence Intervals
Databases, Factual
Debridement - methods
Disease-Free Survival
Drug Administration Schedule
Female
Follow-Up Studies
Hip Prosthesis - adverse effects
Humans
Kaplan-Meier Estimate
Knee Prosthesis - adverse effects
Long-Term Care
Male
Middle Aged
Multivariate Analysis
Orthopedics
Proportional Hazards Models
Prosthesis Failure
Prosthesis-Related Infections - drug therapy
Prosthesis-Related Infections - epidemiology
Prosthesis-Related Infections - microbiology
Retrospective Studies
Risk Assessment
Staphylococcal Infections - drug therapy
Staphylococcal Infections - etiology
Staphylococcus aureus
Treatment Outcome
title Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A47%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20Suppression%20of%20Periprosthetic%20Joint%20Infections%20with%20Oral%20Antibiotics%20Increases%20Infection-Free%20Survivorship&rft.jtitle=Journal%20of%20bone%20and%20joint%20surgery.%20American%20volume&rft.au=Siqueira,%20Marcelo%20B.P.,%20MD&rft.date=2015-08-05&rft.volume=97&rft.issue=15&rft.spage=1220&rft.epage=1232&rft.pages=1220-1232&rft.issn=0021-9355&rft.eissn=1535-1386&rft_id=info:doi/10.2106/JBJS.N.00999&rft_dat=%3Cproquest_cross%3E1811909819%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1702656743&rft_id=info:pmid/26246256&rft_els_id=1_s2_0_S0021935515302125&rfr_iscdi=true